Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MRE11-RAD50-NBS1 (MRN) complex is a highly conserved, multi-protein assembly essential for the detection and repair of DNA double-strand breaks (DSBs). The MRN complex plays central roles in sensing DSBs, processing DNA ends for repair, activating cell cycle checkpoint signaling via ATM/ATR kinases, and tethering and bridging broken DNA ends to facilitate accurate repair. It is comprised of the MRE11 nuclease, the RAD50 ATPase, and the NBS1 regulatory subunit. Mutations in MRN components are associated with severe genomic instability syndromes.
Not applicable, as MRN is a complex, not a single druggable target. Interventions would likely target individual components or downstream pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRE11-RAD50-NBS1 Complex (MRN).